{
  "id": "myasthenia-gravis-crisis",
  "title": "Myasthenia Gravis - Exacerbation/Crisis",
  "version": "1.0",
  "icd10": [
    "** G70.00 (Myasthenia gravis without exacerbation)",
    "G70.01 (Myasthenia gravis with exacerbation)",
    "G70.1 (Toxic myoneural disorders)"
  ],
  "scope": "** Evaluation and management of acute myasthenic exacerbation and myasthenic crisis in adults. Covers respiratory monitoring, immunotherapy (IVIg and plasmapheresis), medications to avoid, and ICU management. Excludes new diagnosis workup, chronic maintenance therapy, Lambert-Eaton myasthenic syndrome (LEMS), and congenital myasthenic syndromes.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential",
          "rationale": "Infection as trigger, baseline",
          "target": "Normal or elevated WBC if infected",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "CMP (BMP + LFTs)",
          "rationale": "Electrolytes, renal/hepatic function",
          "target": "Normal; hypokalemia worsens weakness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Magnesium",
          "rationale": "Hypomagnesemia worsens NMJ transmission",
          "target": ">1.8 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Phosphorus",
          "rationale": "Hypophosphatemia causes weakness",
          "target": ">2.5 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "TSH",
          "rationale": "Thyroid disease common comorbidity",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Blood glucose",
          "rationale": "Hyperglycemia worsens outcomes",
          "target": "<180 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Urinalysis",
          "rationale": "UTI as trigger",
          "target": "Negative for infection",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Blood cultures",
          "rationale": "If febrile or sepsis suspected",
          "target": "Negative",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Procalcitonin",
          "rationale": "Differentiate infection vs non-infectious flare",
          "target": "<0.5 ng/mL if non-infectious",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "ABG or VBG",
          "rationale": "Respiratory status, CO2 retention",
          "target": "PaCO2 <45 mmHg, pH >7.35",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Extended Workup": [
        {
          "item": "AChR (acetylcholine receptor) antibody",
          "rationale": "Confirm diagnosis if unknown",
          "target": "Document if positive (~85% of generalized MG)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "MuSK antibody",
          "rationale": "If AChR negative",
          "target": "Document if positive (~40% of AChR-negative)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "LRP4 antibody",
          "rationale": "If AChR and MuSK negative",
          "target": "Document if positive",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Anti-striated muscle antibody",
          "rationale": "Thymoma association",
          "target": "If positive, CT chest",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Hepatitis B surface antigen",
          "rationale": "Pre-IVIg screening",
          "target": "Negative",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Quantitative immunoglobulins",
          "rationale": "IgA deficiency (IVIg contraindication)",
          "target": "IgA >7 mg/dL",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "PT/INR, PTT",
          "rationale": "Pre-PLEX",
          "target": "Normal",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Type and screen",
          "rationale": "Pre-PLEX",
          "target": "Available",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Fibrinogen",
          "rationale": "Pre-PLEX baseline",
          "target": "Normal",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Troponin",
          "rationale": "Cardiac involvement, stress",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "BNP/NT-proBNP",
          "rationale": "Heart failure assessment",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Cortisol (random or AM)",
          "rationale": "Adrenal insufficiency if on chronic steroids",
          "target": "Normal stress response",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Acetylcholinesterase inhibitor level",
          "rationale": "Cholinergic crisis concern (if available)",
          "target": "Therapeutic range",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Paraneoplastic panel",
          "rationale": "Occult malignancy",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Respiratory viral panel",
          "rationale": "Viral trigger",
          "target": "Document if positive",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "Chest X-ray",
          "timing": "On admission",
          "target": "Aspiration, atelectasis, pneumonia",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "ECG",
          "timing": "On admission",
          "target": "Arrhythmia, QT prolongation",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Forced vital capacity (FVC)",
          "timing": "Serial q4-6h (q2h if declining)",
          "target": "FVC >15-20 mL/kg",
          "contraindications": "Facial weakness limiting seal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Negative inspiratory force (NIF)",
          "timing": "Serial q4-6h (q2h if declining)",
          "target": "NIF more negative than -20 cmH2O",
          "contraindications": "Facial weakness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Extended": [
        {
          "item": "CT chest with contrast",
          "timing": "If thymoma not previously evaluated",
          "target": "Thymoma or thymic hyperplasia",
          "contraindications": "Contrast allergy, renal impairment",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "CT chest without contrast",
          "timing": "Thymoma evaluation (if contrast contraindicated)",
          "target": "Thymic abnormality",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Swallow evaluation",
          "timing": "Bulbar symptoms",
          "target": "Aspiration risk",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Repetitive nerve stimulation",
          "timing": "If diagnosis uncertain",
          "target": "Decremental response >10%",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Single-fiber EMG",
          "timing": "If RNS negative but MG suspected",
          "target": "Increased jitter, blocking",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "PET-CT",
          "timing": "Occult thymoma or malignancy",
          "target": "Tumor identification",
          "contraindications": "Hemodynamic instability",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Ice pack test",
          "timing": "Bedside diagnostic (ptosis)",
          "target": "Improvement with cooling",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent - Airway and Respiratory Support": [
        {
          "item": "Supplemental oxygen",
          "route": "INH",
          "indication": "Hypoxemia",
          "dosing": {
            "doseOptions": [
              {
                "text": "2-6 L/min NC",
                "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
              },
              {
                "text": "15 L/min NRB",
                "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
              }
            ],
            "route": "INH",
            "instructions": "Titrate to O2 sat >94%; escalate as needed",
            "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
          },
          "contraindications": "None",
          "monitoring": "O2 sat, RR",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Endotracheal intubation",
          "route": "—",
          "indication": "Respiratory failure",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Endotracheal intubation N/A —"
              }
            ],
            "route": "—",
            "instructions": "Intubate if FVC <15 mL/kg, NIF >-20 cmH2O, or clinical deterioration; AVOID succinylcholine (may have prolonged block); use rocuronium (may need higher dose)",
            "orderSentence": "Endotracheal intubation N/A —"
          },
          "contraindications": "—",
          "monitoring": "ETT position, ventilator settings",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Non-invasive ventilation (BiPAP)",
          "route": "—",
          "indication": "Bridge to intubation or mild hypoventilation",
          "dosing": {
            "doseOptions": [
              {
                "text": "IPAP 10-15",
                "orderSentence": "Non-invasive ventilation (BiPAP) IPAP 10-15 —"
              },
              {
                "text": "EPAP 5",
                "orderSentence": "Non-invasive ventilation (BiPAP) EPAP 5 —"
              }
            ],
            "route": "—",
            "instructions": "BiPAP may temporize; NOT a substitute for intubation in true crisis",
            "orderSentence": "Non-invasive ventilation (BiPAP) IPAP 10-15 —"
          },
          "contraindications": "Severe respiratory failure, inability to protect airway",
          "monitoring": "RR, TV, O2 sat, CO2",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Mechanical ventilation",
          "route": "—",
          "indication": "Respiratory failure",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Mechanical ventilation N/A —"
              }
            ],
            "route": "—",
            "instructions": "Lung-protective ventilation; expect prolonged wean; daily SBT when improved",
            "orderSentence": "Mechanical ventilation N/A —"
          },
          "contraindications": "—",
          "monitoring": "ABG, ventilator parameters",
          "ED": "—",
          "HOSP": "—",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Immunotherapy - First-line for Crisis/Severe Exacerbation": [
        {
          "item": "IVIg (immune globulin IV)",
          "route": "IV",
          "indication": "Myasthenic crisis or severe exacerbation",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg/day x 5 days",
                "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
              },
              {
                "text": "1 g/kg/day x 2 days",
                "orderSentence": "IVIg (immune globulin IV) 1 g/kg/day x 2 days IV"
              }
            ],
            "route": "IV",
            "instructions": "0.4 g/kg/day IV for 5 days (preferred) OR 1 g/kg/day x 2 days; infuse slowly day 1",
            "orderSentence": "IVIg (immune globulin IV) 0.4 g/kg/day x 5 days IV"
          },
          "contraindications": "IgA deficiency with anti-IgA antibodies; severe renal impairment; recent MI/stroke (thrombosis risk)",
          "monitoring": "Renal function daily, headache, infusion reactions; pre-medicate",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Plasmapheresis (PLEX)",
          "route": "—",
          "indication": "Myasthenic crisis or severe exacerbation",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 exchanges over 7-14 days",
                "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 7-14 days —"
              }
            ],
            "route": "—",
            "instructions": "5 exchanges (1-1.5 plasma volumes per exchange) over 7-14 days; typically QOD",
            "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 7-14 days —"
          },
          "contraindications": "Hemodynamic instability, severe sepsis, poor IV access",
          "monitoring": "BP, electrolytes, coagulation, fibrinogen",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Cholinesterase Inhibitors": [
        {
          "item": "Pyridostigmine",
          "route": "PO",
          "indication": "Symptomatic treatment",
          "dosing": {
            "doseOptions": [
              {
                "text": "30 mg TID",
                "orderSentence": "Pyridostigmine 30 mg TID PO"
              },
              {
                "text": "60 mg TID",
                "orderSentence": "Pyridostigmine 60 mg TID PO"
              },
              {
                "text": "60 mg QID",
                "orderSentence": "Pyridostigmine 60 mg QID PO"
              },
              {
                "text": "90 mg QID",
                "orderSentence": "Pyridostigmine 90 mg QID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 30-60 mg TID; titrate by 30 mg/dose q2-3d; max ~120 mg q4h; usual maintenance 60-90 mg q4-6h",
            "orderSentence": "Pyridostigmine 30 mg TID PO"
          },
          "contraindications": "Mechanical bowel/bladder obstruction",
          "monitoring": "Cholinergic symptoms (SLUDGE), HR",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Pyridostigmine (in crisis)",
          "route": "—",
          "indication": "During crisis",
          "dosing": {
            "doseOptions": [
              {
                "text": "HOLD or reduce",
                "orderSentence": "Pyridostigmine (in crisis) HOLD or reduce —"
              }
            ],
            "route": "—",
            "instructions": "HOLD pyridostigmine in intubated patients or suspected cholinergic crisis; restart at low dose when improving",
            "orderSentence": "Pyridostigmine (in crisis) HOLD or reduce —"
          },
          "contraindications": "Cholinergic crisis",
          "monitoring": "Secretions, HR",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Neostigmine",
          "route": "IV/IM",
          "indication": "If NPO and needs AChEI",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg IV q3h",
                "orderSentence": "Neostigmine 0.5 mg IV q3h IV/IM"
              },
              {
                "text": "1.5 mg IM q3h",
                "orderSentence": "Neostigmine 1.5 mg IM q3h IV/IM"
              }
            ],
            "route": "IV/IM",
            "instructions": "0.5 mg IV or 1.5 mg IM roughly equivalent to 60 mg PO pyridostigmine; use ONLY if cannot take PO and essential",
            "orderSentence": "Neostigmine 0.5 mg IV q3h IV/IM"
          },
          "contraindications": "Cholinergic toxicity",
          "monitoring": "HR, secretions",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Glycopyrrolate",
          "route": "PO/IV",
          "indication": "Cholinergic side effects",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 mg PO TID",
                "orderSentence": "Glycopyrrolate 1 mg PO TID PO/IV"
              },
              {
                "text": "0.2 mg IV PRN",
                "orderSentence": "Glycopyrrolate 0.2 mg IV PRN PO/IV"
              }
            ],
            "route": "PO/IV",
            "instructions": "1-2 mg PO TID for secretions/GI effects; 0.2 mg IV PRN; does not cross BBB",
            "orderSentence": "Glycopyrrolate 1 mg PO TID PO/IV"
          },
          "contraindications": "Glaucoma, severe cardiac disease",
          "monitoring": "HR, urinary retention",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ],
      "Corticosteroids (Use with CAUTION)": [
        {
          "item": "Prednisone (high-dose, post-crisis)",
          "route": "PO",
          "indication": "Crisis treated with IVIg/PLEX, improving",
          "dosing": {
            "doseOptions": [
              {
                "text": "60 mg daily",
                "orderSentence": "Prednisone (high-dose, post-crisis) 60 mg daily PO"
              },
              {
                "text": "1 mg/kg daily",
                "orderSentence": "Prednisone (high-dose, post-crisis) 1 mg/kg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 60 mg (or 1 mg/kg) daily AFTER day 3 of IVIg/PLEX if improving; for patients whose crisis is being treated; taper once stable",
            "orderSentence": "Prednisone (high-dose, post-crisis) 60 mg daily PO"
          },
          "contraindications": "Active infection (relative)",
          "monitoring": "Glucose, BP, K+; already covered by IVIg/PLEX",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Prednisone (low-dose start)",
          "route": "PO",
          "indication": "Stable patient, outpatient, new start",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg daily",
                "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
              },
              {
                "text": "20 mg daily",
                "orderSentence": "Prednisone (low-dose start) 20 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start LOW (10-20 mg daily) and increase slowly by 10 mg q5-7d to target 1 mg/kg/day; for OUTPATIENT or STABLE inpatients not in crisis; HIGH-DOSE INITIATION CAN WORSEN MG",
            "orderSentence": "Prednisone (low-dose start) 10 mg daily PO"
          },
          "contraindications": "Active infection (relative), brittle MG without IVIg/PLEX cover",
          "monitoring": "Glucose, BP, K+; WATCH FOR TRANSIENT WORSENING days 5-10",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE",
          "ICU": "—"
        },
        {
          "item": "Methylprednisolone",
          "route": "IV",
          "indication": "Severe exacerbation (with IVIg/PLEX cover)",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg daily x 3-5 days",
                "orderSentence": "Methylprednisolone 500 mg daily x 3-5 days IV"
              },
              {
                "text": "1000 mg daily x 3-5 days",
                "orderSentence": "Methylprednisolone 1000 mg daily x 3-5 days IV"
              }
            ],
            "route": "IV",
            "instructions": "500-1000 mg IV daily x 3-5 days; ONLY with IVIg/PLEX coverage due to risk of transient worsening",
            "orderSentence": "Methylprednisolone 500 mg daily x 3-5 days IV"
          },
          "contraindications": "Active untreated infection",
          "monitoring": "Glucose, BP, K+, psychiatric effects",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        }
      ],
      "Supportive Care": [
        {
          "item": "Enoxaparin",
          "route": "SC",
          "indication": "DVT prophylaxis",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg daily",
                "orderSentence": "Enoxaparin 40 mg daily SC"
              },
              {
                "text": "30 mg BID",
                "orderSentence": "Enoxaparin 30 mg BID SC"
              }
            ],
            "route": "SC",
            "instructions": "40 mg SC daily; 30 mg BID if BMI >40; hold if CrCl <30; **HOLD if LP planned within 12 hours**",
            "orderSentence": "Enoxaparin 40 mg daily SC"
          },
          "contraindications": "Active bleeding, HIT, pending LP",
          "monitoring": "Platelet count, bleeding",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Heparin (UFH)",
          "route": "SC",
          "indication": "DVT prophylaxis (renal impairment)",
          "dosing": {
            "doseOptions": [
              {
                "text": "5000 units q8h",
                "orderSentence": "Heparin (UFH) 5000 units q8h SC"
              },
              {
                "text": "5000 units q12h",
                "orderSentence": "Heparin (UFH) 5000 units q12h SC"
              }
            ],
            "route": "SC",
            "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
            "orderSentence": "Heparin (UFH) 5000 units q8h SC"
          },
          "contraindications": "Active bleeding, HIT, pending LP",
          "monitoring": "Platelet count",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Famotidine",
          "route": "IV/PO",
          "indication": "Stress ulcer prophylaxis (if on steroids)",
          "dosing": {
            "doseOptions": [
              {
                "text": "20 mg BID",
                "orderSentence": "Famotidine 20 mg BID IV/PO"
              },
              {
                "text": "40 mg daily",
                "orderSentence": "Famotidine 40 mg daily IV/PO"
              }
            ],
            "route": "IV/PO",
            "instructions": "20 mg IV/PO BID or 40 mg daily",
            "orderSentence": "Famotidine 20 mg BID IV/PO"
          },
          "contraindications": "None significant",
          "monitoring": "None",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Insulin (regular)",
          "route": "IV/SC",
          "indication": "Steroid-induced hyperglycemia",
          "dosing": {
            "doseOptions": [
              {
                "text": "Sliding scale",
                "orderSentence": "Insulin (regular) Sliding scale IV/SC"
              },
              {
                "text": "basal-bolus",
                "orderSentence": "Insulin (regular) basal-bolus IV/SC"
              }
            ],
            "route": "IV/SC",
            "instructions": "Sliding scale or basal-bolus; target glucose <180 mg/dL",
            "orderSentence": "Insulin (regular) Sliding scale IV/SC"
          },
          "contraindications": "Hypoglycemia",
          "monitoring": "Glucose q4-6h",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Acetaminophen",
          "route": "PO/IV",
          "indication": "Fever, mild pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "650 mg q6h",
                "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
              },
              {
                "text": "1000 mg q6h",
                "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
              }
            ],
            "route": "PO/IV",
            "instructions": "650-1000 mg q6h; max 4 g/day",
            "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
          },
          "contraindications": "Severe hepatic impairment",
          "monitoring": "LFTs if prolonged",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "SCDs (sequential compression devices)",
          "route": "—",
          "indication": "DVT prophylaxis",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "SCDs (sequential compression devices) N/A —"
              }
            ],
            "route": "—",
            "instructions": "Bilateral lower extremity SCDs",
            "orderSentence": "SCDs (sequential compression devices) N/A —"
          },
          "contraindications": "DVT in that extremity",
          "monitoring": "Skin integrity",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Long-term Immunosuppression (Initiate/Continue as Indicated)": [
        {
          "item": "Azathioprine",
          "route": "PO",
          "indication": "Steroid-sparing agent",
          "dosing": {
            "doseOptions": [
              {
                "text": "50 mg daily",
                "orderSentence": "Azathioprine 50 mg daily PO"
              },
              {
                "text": "100 mg daily",
                "orderSentence": "Azathioprine 100 mg daily PO"
              },
              {
                "text": "150 mg daily",
                "orderSentence": "Azathioprine 150 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 50 mg daily; increase by 50 mg q2-4wk to 2-3 mg/kg/day; check TPMT before starting",
            "orderSentence": "Azathioprine 50 mg daily PO"
          },
          "contraindications": "TPMT deficiency, pregnancy",
          "monitoring": "CBC weekly x 4, then monthly; LFTs monthly",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "—"
        },
        {
          "item": "Mycophenolate mofetil",
          "route": "PO",
          "indication": "Steroid-sparing agent",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mg BID",
                "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
              },
              {
                "text": "1000 mg BID",
                "orderSentence": "Mycophenolate mofetil 1000 mg BID PO"
              },
              {
                "text": "1500 mg BID",
                "orderSentence": "Mycophenolate mofetil 1500 mg BID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 500 mg BID; increase to 1000-1500 mg BID over 2-4 weeks",
            "orderSentence": "Mycophenolate mofetil 500 mg BID PO"
          },
          "contraindications": "Pregnancy, hypersensitivity",
          "monitoring": "CBC q2wk x 2mo, then monthly; LFTs",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "—"
        },
        {
          "item": "Rituximab",
          "route": "IV",
          "indication": "Refractory MG, MuSK-positive MG",
          "dosing": {
            "doseOptions": [
              {
                "text": "375 mg/m² weekly x 4 weeks",
                "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
              },
              {
                "text": "1000 mg q2wk x 2",
                "orderSentence": "Rituximab 1000 mg q2wk x 2 IV"
              }
            ],
            "route": "IV",
            "instructions": "375 mg/m² weekly x 4 OR 1000 mg x 2 doses (2 weeks apart); pre-medicate with methylpred, acetaminophen, diphenhydramine",
            "orderSentence": "Rituximab 375 mg/m² weekly x 4 weeks IV"
          },
          "contraindications": "Active infection, HBV (screen first)",
          "monitoring": "Infusion reactions, CD19/CD20, immunoglobulins",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology consult",
          "indication": "All MG exacerbations",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Pulmonology consult",
          "indication": "Respiratory compromise, ventilator wean",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Critical care consult",
          "indication": "FVC <20 mL/kg, impending crisis",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Thoracic surgery consult",
          "indication": "Thymoma identified, thymectomy planning",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Speech therapy consult",
          "indication": "Bulbar symptoms, dysphagia",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Physical therapy consult",
          "indication": "Mobility, fall prevention",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Occupational therapy consult",
          "indication": "ADL assessment, energy conservation",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Respiratory therapy",
          "indication": "Airway clearance, pulmonary toilet",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Pharmacy consult",
          "indication": "Medication safety review",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Social work",
          "indication": "Support resources, discharge planning",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Return immediately for worsening weakness or breathing difficulty",
          "ED": "STAT",
          "HOSP": "—",
          "OPD": "STAT"
        },
        {
          "item": "Do not skip or suddenly stop immunosuppressive medications",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Carry MG medical alert card listing medications to avoid",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Take pyridostigmine 30-60 minutes before meals if dysphagia",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report fever or signs of infection promptly",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Avoid extreme heat (worsens symptoms)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Get adequate rest, avoid overexertion",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Do not drive if diplopia or ptosis impairs vision",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Myasthenia Gravis Foundation resources (www.myasthenia.org)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Aspiration precautions if bulbar weakness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—"
        },
        {
          "item": "Fall precautions for all MG patients",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Medication reconciliation before any new prescription",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Vaccinations: avoid live vaccines on immunosuppression; flu and pneumococcal recommended",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Stress management (stress can trigger exacerbation)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Sleep hygiene",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Energy conservation techniques",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Guillain-Barré syndrome",
      "features": "Ascending weakness, areflexia, no fluctuation",
      "tests": "CSF (albuminocytologic dissociation), EMG/NCS"
    },
    {
      "diagnosis": "Lambert-Eaton syndrome",
      "features": "Proximal weakness, autonomic symptoms, reflexes improve with exercise",
      "tests": "VGCC antibodies, EMG (incremental response)"
    },
    {
      "diagnosis": "Botulism",
      "features": "Descending weakness, pupil involvement, GI symptoms",
      "tests": "Stool/serum toxin, EMG"
    },
    {
      "diagnosis": "Brainstem stroke",
      "features": "Acute onset, crossed findings, other cranial nerve signs",
      "tests": "MRI brain"
    },
    {
      "diagnosis": "Multiple sclerosis",
      "features": "CNS symptoms, sensory involvement, different time course",
      "tests": "MRI brain/spine, CSF"
    },
    {
      "diagnosis": "Thyroid eye disease",
      "features": "Thyroid dysfunction, proptosis, restrictive ophthalmopathy",
      "tests": "TFTs, orbital imaging"
    },
    {
      "diagnosis": "Oculopharyngeal muscular dystrophy",
      "features": "Older onset, slowly progressive, no fluctuation",
      "tests": "Genetic testing, muscle biopsy"
    },
    {
      "diagnosis": "Mitochondrial myopathy",
      "features": "Progressive, elevated lactate, other organ involvement",
      "tests": "Lactate, muscle biopsy, genetic testing"
    },
    {
      "diagnosis": "Drug-induced MG",
      "features": "Recent D-penicillamine, checkpoint inhibitors",
      "tests": "Medication history, antibodies"
    },
    {
      "diagnosis": "Cholinergic crisis",
      "features": "SLUDGE symptoms, miosis, bradycardia",
      "tests": "Clinical, response to stopping AChEI"
    }
  ],
  "evidence": [
    {
      "recommendation": "IVIg and PLEX equally effective for MG exacerbation",
      "evidenceLevel": "Class I, Level A",
      "source": "[Gajdos et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235604/)"
    },
    {
      "recommendation": "IVIg 2 g/kg total dose standard",
      "evidenceLevel": "Class I, Level A",
      "source": "[Zinman et al. Lancet Neurol 2007](https://pubmed.ncbi.nlm.nih.gov/17706563/)"
    },
    {
      "recommendation": "PLEX effective for MG crisis",
      "evidenceLevel": "Class I, Level A",
      "source": "[Gajdos et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/23235604/)"
    },
    {
      "recommendation": "FVC and NIF for respiratory monitoring",
      "evidenceLevel": "Class II, Level B",
      "source": "[Rabinstein & Wijdicks. Neurology 2003](https://pubmed.ncbi.nlm.nih.gov/12654988/)"
    },
    {
      "recommendation": "Pyridostigmine for symptomatic treatment",
      "evidenceLevel": "Class I, Level A",
      "source": "[Mehndiratta et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25304970/)"
    },
    {
      "recommendation": "Corticosteroids can cause initial worsening",
      "evidenceLevel": "Class II, Level B",
      "source": "[Palace et al. Lancet Neurol 2012](https://pubmed.ncbi.nlm.nih.gov/22305458/)"
    },
    {
      "recommendation": "Azathioprine as steroid-sparing agent",
      "evidenceLevel": "Class I, Level B",
      "source": "[Palace et al. NEJM 1998](https://pubmed.ncbi.nlm.nih.gov/9771070/)"
    },
    {
      "recommendation": "Rituximab effective in refractory/MuSK+ MG",
      "evidenceLevel": "Class II, Level C",
      "source": "[Nowak et al. Neurology 2022](https://pubmed.ncbi.nlm.nih.gov/34986310/)"
    },
    {
      "recommendation": "Medications to avoid in MG",
      "evidenceLevel": "Class III, Level C",
      "source": "[Juel. Semin Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15257515/)"
    },
    {
      "recommendation": "Thymectomy beneficial in generalized MG",
      "evidenceLevel": "Class I, Level B",
      "source": "[Wolfe et al. NEJM 2016 (MGTX Trial)](https://pubmed.ncbi.nlm.nih.gov/27509102/)"
    }
  ],
  "monitoring": [
    {
      "item": "Forced vital capacity (FVC)",
      "frequency": "q4-6h; q2h if declining",
      "action": "Intubate if <15 mL/kg",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Negative inspiratory force (NIF)",
      "frequency": "q4-6h; q2h if declining",
      "action": "Intubate if weaker than -20 cmH2O",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Oxygen saturation",
      "frequency": "Continuous",
      "action": "Supplement O2, consider intubation",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Neurological exam (strength)",
      "frequency": "q4-8h",
      "action": "Escalate therapy if worsening",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT"
    },
    {
      "item": "Swallow function",
      "frequency": "Daily if bulbar symptoms",
      "action": "NPO, NG tube if unsafe",
      "ED": "—",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Blood glucose",
      "frequency": "q6h if on steroids",
      "action": "Insulin adjustment",
      "ED": "—",
      "HOSP": "ROUTINE",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Renal function",
      "frequency": "Daily during IVIg",
      "action": "Hold IVIg, hydrate if rising",
      "ED": "—",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Electrolytes (K+, Mg)",
      "frequency": "Daily",
      "action": "Replete aggressively",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Heart rate/rhythm",
      "frequency": "Continuous",
      "action": "Evaluate for autonomic dysfunction",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Blood pressure",
      "frequency": "q4h",
      "action": "Evaluate for autonomic dysfunction",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Cholinergic symptoms",
      "frequency": "Each dose of pyridostigmine",
      "action": "Reduce dose, consider cholinergic crisis",
      "ED": "—",
      "HOSP": "ROUTINE",
      "OPD": "—",
      "ICU": "ROUTINE"
    }
  ],
  "disposition": [
    {
      "disposition": "**ICU admission**",
      "criteria": "FVC <20 mL/kg or declining; NIF weaker than -30 cmH2O; rapid progression; bulbar dysfunction with aspiration risk; need for intubation/BiPAP"
    },
    {
      "disposition": "**Step-down/telemetry**",
      "criteria": "Stable FVC >20 mL/kg; improving or stable exam; receiving IVIg/PLEX; no bulbar symptoms"
    },
    {
      "disposition": "**General floor**",
      "criteria": "Mild exacerbation; FVC >30 mL/kg and stable; no bulbar symptoms; stable on oral medications"
    },
    {
      "disposition": "**Discharge home**",
      "criteria": "Stable or improved x 24-48 hours; FVC stable >30 mL/kg; adequate oral intake; medications optimized; outpatient follow-up arranged"
    },
    {
      "disposition": "**Acute rehabilitation**",
      "criteria": "Significant residual weakness after crisis; requires intensive therapy; medically stable"
    }
  ]
}